Literature DB >> 15907286

Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy.

Fabio Galetta1, Ferdinando Franzoni, Roberto Sposito, Yvonne Plantinga, Francesca Romana Femia, Fabio Galluzzi, Anna Rocchi, Gino Santoro, Gabriele Siciliano.   

Abstract

Myocardial involvement is a common finding in certain myopathies, while it has not been extensively investigated in facioscapulohumeral muscular dystrophy (FSHD1A). Aim of this study was to assess in FSHD1A patients the electrical and functional properties of the myocardium. Twenty-four patients with FSHD1A (mean age 41.2+/-14.5 years) and 24 matched healthy subjects were studied. Standard- and signal-averaged electrocardiography were recorded to determine QT dispersion and the presence of ventricular late potentials (VLPs). Standard echocardiography with systo-diastolic variations of integrated backscatter signal (CV-IBS) were performed to assess functional properties of the myocardium. Compared with control subjects, patients with FSHD1A had significantly lower CV-IBS and higher QT dispersion. Nine patients had positive VLPs. QT and QTc dispersion were inversely related to CV-IBS at both septum and posterior wall levels. Moreover, septal CV-IBS was inversely related to the Kpnl-BinI4q fragment size. These results suggest a subclinical cardiac involvement in FSHD1A patients, which can represent a substrate for ventricular arrhythmias and heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 15907286     DOI: 10.1016/j.nmd.2005.02.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

1.  Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.

Authors:  Rianne J M Goselink; Karlien Mul; Caroline R van Kernebeek; Richard J L F Lemmers; Silvère M van der Maarel; Tim H A Schreuder; Corrie E Erasmus; George W Padberg; Jeffrey M Statland; Nicol C Voermans; Baziel G M van Engelen
Journal:  Neurology       Date:  2018-12-19       Impact factor: 9.910

2.  High prevalence of incomplete right bundle branch block in facioscapulohumeral muscular dystrophy without cardiac symptoms.

Authors:  Gaby Pons van Dijk; Elly van der Kooi; Anthony Behin; Joep Smeets; Janneke Timmermans; Silvère van der Maarel; George Padberg; Nicol Voermans; Baziel van Engelen
Journal:  Funct Neurol       Date:  2014 Jul-Sep

3.  Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  Allison Ducharme-Smith; Stefan Nicolau; C Anwar A Chahal; Kirstie Ducharme-Smith; Shujah Rehman; Keerthi Jaliparthy; Nadeem Khan; Christopher G Scott; Erik K St Louis; Teerin Liewluck; Virend K Somers; Grace Lin; Peter A Brady; Margherita Milone
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

4.  Intermittent pre-excitation-syndrome in facio-scapulo-humeral muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger; Edmund Gatterer; Sibylle Jakubiczka
Journal:  Korean Circ J       Date:  2014-09-25       Impact factor: 3.243

Review 5.  Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.

Authors:  Alberto Palladino; Paola D'Ambrosio; Andrea Antonio Papa; Roberta Petillo; Chiara Orsini; Marianna Scutifero; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2016-12

6.  Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Mol Ther Methods Clin Dev       Date:  2020-12-10       Impact factor: 6.698

7.  Evaluation of Myocardial Strain by 2-Dimensional Speckle Tracking Echocardiography in Patients with Facioscapulohumeral Muscular Dystrophy.

Authors:  Ferhat Işık; Abdurrahman Akyüz; Murat Çap; Askeri Türken; Süleyman Varsak; Erkan Baysal
Journal:  Anatol J Cardiol       Date:  2022-07       Impact factor: 1.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.